Jurickson Profar has been suspended for the entire 2026 regular season and postseason after failing a PED test; the MLBPA's appeal did not overturn the ruling. The Braves now have about $18 million to spend and Profar will not play in 2026, with his future with the team uncertain.
Jurickson Profar’s appeal of his 162-game suspension for a second PED positive was denied, meaning he’ll miss the entire 2026 season and be ineligible for postseason if Atlanta makes it. He won’t receive his $15 million salary, saving the Braves about $18 million in payroll and luxury taxes (roughly $15M salary plus $3M tax). The Braves have little urgency to replace him immediately, though they could explore free-agent pitchers like Giolito or Anderson as they reassess their roster. Profar remains under contract through 2027, leaving a future decision for next year, and another positive test would bring a lifetime ban after three PED suspensions.
MLB suspended Phillies center fielder Johan Rojas for 80 games after a positive test for Boldenone under the Joint Drug Prevention and Treatment Program; the ban begins in 2026, ruling him out for at least the first half and leaving Philadelphia thinner at center field as they lean on Harrison Bader, Justin Crawford, Pedro León, and Dylan Moore to cover the position. Rojas has been strong defensively but hit only .237/.279/.312 with a 64 wRC+ since 2024, and suspensions also bar postseason eligibility for the player.
World Baseball Classic kicks off in Tokyo with notable rosters as the 2026 season looms; Jurickson Profar faces a 162-game PED suspension and Johan Rojas reportedly faces an 80-game ban, both likely to be appealed, leaving the Braves and Phillies reworking Opening Day plans. Profar’s absence could free payroll and create DH/outfield vacancies, prompting potential adds such as Lucas Giolito or Zack Littell and a bat like Dominic Smith, Ben Gamel, or Tristin English for Atlanta, while injuries to Schwellenbach and Waldrep strain depth. Philadelphia will lean on top prospect Justin Crawford with Pedro León and Bryan De La Cruz in the mix for outfield depth. The interplay of WBC action and suspensions could reshape NL East plans ahead of opening day.
MLB suspended Braves outfielder Jurickson Profar for 162 games after a second PED violation (exogenous testosterone); the penalty begins Friday, and the Players Association plans an expedited appeal. Second offenses can be appealed but carry no stay, while first-time penalties are stayed during appeal. Profar previously missed 80 games in 2025 for hCG. The Braves face roster and luxury-tax implications as they move into 2026 without him.
Braves outfielder Jurickson Profar has been suspended 162 games for a second PED violation, ending his 2026 season and making him ineligible for the World Baseball Classic; the team now faces DH lineup questions as spring training approaches.
Phillies center fielder Johan Rojas reportedly tested positive for a performance-enhancing drug and plans to appeal the ruling. A first-time PED violation carries an 80-game suspension, though there has been no formal announcement from MLB or the Phillies yet. The outcome could affect Philadelphia’s outfield depth and playing time in 2026.
Braves outfielder Jurickson Profar faces a 162-game suspension for a second PED violation, with MLB and the union likely to pursue a grievance to an independent arbitrator. If imposed, he would miss the season and postseason and forfeit about $15 million of this year’s $42 million contract; Profar previously served an 80-game ban for hCG, and Atlanta must navigate his absence as spring training continues and replacements are considered.
Boxer Ryan Garcia has been suspended for one year by the New York State Athletic Commission and must forfeit the $1 million he won from his fight against Devin Haney after testing positive for the performance-enhancing drug ostarine. The fight result has been changed to a no-contest, and Garcia has also been fined $10,000.